BeStock  
Stocks › Biotechnology › BRVE

Braveheart Bio BRVE

US equityMarket cap rank #2736Biotechnology
$20.39 +$1.12 (+5.81%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $20.39 0.00%
Open$19.29
Prev close$19.27
Day range$18.83 – $21.16
Volume866.7K
Market cap$1.83B
P/E (TTM)–
Dividend yield–

BRVE Stock News

Headlines matching Braveheart Bio or the BRVE ticker, most recent first.

  • Goldman Sachs Remains a Buy on Braveheart Bio, Inc. (BRVE)TipRanks · 9 Sep 2026 · Direct mention
  • Goldman Sachs Maintains Braveheart Bio(BRVE.US) With Buy Rating, Maintains Target Price $48Market news · 9 Sep 2026 · Direct mention
  • Analysts Offer Insights on NA Companies: IMAX (IMAX) and Braveheart Bio, Inc. (BRVE)TipRanks · 9 Sep 2026 · Direct mention
  • Analysts Offer Insights on NA Companies: Braveheart Bio, Inc. (BRVE) and TeraWulf Inc (WULF)TipRanks · 7 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Braveheart Bio(BRVE.US), With a Forecast Between $40 to $48Market news · 1 Sep 2026 · Direct mention
  • Goldman Sachs Maintains Braveheart Bio(BRVE.US) With Buy Rating, Raises Target Price to $49 PositiveMarket news · 12 Nov 2026 · Direct mention
  • Stifel Maintains Braveheart Bio(BRVE.US) With Buy Rating, Maintains Target Price $45Market news · 10 Nov 2026 · Direct mention
  • Braveheart Bio, Inc. (BRVE) Receives a Buy From Cantor FitzgeraldTipRanks · 20 Oct 2026 · Direct mention
  • Cantor Fitzgerald Maintains Braveheart Bio(BRVE.US) With Buy Rating, Maintains Target Price $40Market news · 20 Oct 2026 · Direct mention
  • Stifel Nicolaus Remains a Buy on Braveheart Bio, Inc. (BRVE)TipRanks · 1 Oct 2026 · Direct mention
  • Stifel Maintains Braveheart Bio(BRVE.US) With Buy Rating, Maintains Target Price $45Market news · 1 Oct 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on BRVE.

Sign in to join the discussion.

Scroll to Top